BIOMAT Database Logo BIOMAT Database Logo

Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts. 2007

K Sandy Pang, and Michael Weiss, and Panos Macheras
Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, Canada M5S 3M2. ks.pang@utoronto.ca

Three advanced models of pharmacokinetics are described. In the first class are physiologically based pharmacokinetic models based on in vitro data on transport and metabolism. The information is translated as transporter and enzyme activities and their attendant heterogeneities into liver and intestine models. Second are circulatory models based on transit time distribution and plasma concentration time curves. The third are fractal models for nonhomogeneous systems and non-Fickian processes are presented. The usefulness of these pharmacokinetic models, with examples, is compared.

UI MeSH Term Description Entries
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010599 Pharmacokinetics Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology. ADME,ADME-Tox,ADMET,Absorption, Distribution, Metabolism, Elimination, and Toxicology,Absorption, Distribution, Metabolism, and Elimination,Drug Kinetics,Kinetics, Drug,LADMER,Liberation, Absorption, Distribution, Metabolism, Elimination, and Response
D001775 Blood Circulation The movement of the BLOOD as it is pumped through the CARDIOVASCULAR SYSTEM. Blood Flow,Circulation, Blood,Blood Flows,Flow, Blood
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

K Sandy Pang, and Michael Weiss, and Panos Macheras
Clearance constants in physiologically based pharmacokinetic models.
August 1979, Journal of pharmaceutical sciences,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Criticism of pharmacokinetic clearance concepts.
November 1983, International journal of clinical pharmacology, therapy, and toxicology,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Process and System Clearances in Pharmacokinetic Models: Our Basic Clearance Concepts Are Correct.
April 2023, Drug metabolism and disposition: the biological fate of chemicals,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Organ clearance concepts: new perspectives on old principles.
August 1997, Journal of pharmacokinetics and biopharmaceutics,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Clearance Concepts: Fundamentals and Application to Pharmacokinetic Behavior of Drugs.
January 2018, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.
January 1981, European journal of clinical pharmacology,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Applying organ clearance concepts in a clinical setting.
October 2008, American journal of pharmaceutical education,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Physiologically based pharmacokinetic models of small molecules and therapeutic antibodies: a mini-review on fundamental concepts and applications.
March 2016, Biopharmaceutics & drug disposition,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Fractal models for event-based and dynamical timers.
February 2008, Acta psychologica,
K Sandy Pang, and Michael Weiss, and Panos Macheras
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
August 2009, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!